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Abstract: The number of percutaneous coronary interventions (PCI) prior to coronary artery 
bypass grafting (CABG) increased drastically during the last decade. Patients are referred for 
CABG with more severe coronary pathology, which may influence postoperative outcome. 
Outcomes of 200 CABG patients, collected consecutively in an observational study, were 
compared (mean follow-up: 5 years). Group A (n = 100, mean age 63 years, 20 women) had 
prior PCI before CABG, and group B (n = 100, mean age 66, 20 women) underwent primary 
CABG. In group A, the mean number of administered stents was 2. Statistically significant 
results were obtained for the following preoperative criteria: previous myocardial infarction: 
54 vs 34 (P = 0.007), distribution of CAD (P , 0.0001), unstable angina: 27 vs 5 (P , 0.0001). 
For intraoperative data, the total number of established bypasses was 2.43 ± 1.08 vs 2.08 ± 1.08 
(P = 0.017), with the number of arterial bypass grafts being: 1.26 ± 0.82 vs 1.07 ± 0.54 (P = 0.006). 
Regarding the postoperative course, significant results could be demonstrated for: adrenaline 
dosage (0.83 vs 0.41 mg/h; [p is not significant (ns)]) administered in 67 group A vs 47 group B 
patients (P = 0.006), and noradrenaline dosage (0.82 vs 0.87 mg/h; ns) administered in 46 group 
A vs 63 group B patients (P = 0.023), CK/troponine I (P = 0.002; P , 0.001), postoperative 
resuscitation (6 vs 0; P = 0.029), intra aortic balloon pump 12 vs 1 (P = 0.003), and 30-day 
mortality (9% in group A vs 1% in group B; P = 0.018). Clopidogrel was administered in 35% 
of patients with prior PCI and in 19% of patients without prior PCI (P = 0.016). Patients with 
prior PCI presented for CABG with more severe CAD. Morbidity, mortality and reoperation 
rate during mid term were significantly higher in patients with prior PCI.
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Introduction
Acceptance of percutanous coronary intervention (PCI) and use in patients with 
symptomatic coronary artery disease (CAD) has drastically expanded during the last 
decade,1,2 whereas rates of coronary artery bypass grafting (CABG) have a decreasing 
tendency.2,3
Randomized trials conducted before and after the implementation of intracoronary 
stents have demonstrated comparable long-term survival between patients undergoing 
PCI and patients undergoing CABG for single and/or multivessel CAD.4–6 While PCI 
was offered only to patients with isolated coronary lesions and single-vessel disease 
years ago, it is now being used with higher frequency in a broader spectrum of patients. 
Consequently, a number of referred patients had received PCI, some multiple times, 
before undergoing CABG.
Results from medical literature comparing PCI and CABG have shown that initial 
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Dovepress 
Dovepress
496
Eifert et al
than patients who undergo CABG initially.7–16 Although 
numerous studies have established that reoperative CABG 
is associated with increased perioperative and long-term 
mortality and morbidity,17–20 knowledge of outcomes in 
patients who undergo PCI prior to CABG is limited. The 
objective of this study was to compare the outcomes, includ-
ing mortality, of group A and group B.
Patients and methods
Patient population
Two hundred patients who underwent CABG between 
January 2001 and June 2003 at the Department of Car-
diac Surgery at the University Hospital of Munich were 
consecutively observed for our study. Group A included 
100 patients (20 women) who had undergone PCI with the 
implantation of a minimum of one stent prior to CABG, at 
an average of 321.2 ± 501.8 days before surgery. Among 
them, in 70 patients, bare metal stents, and in 30 patients, 
drug-eluting stents were applied. The other 100 patients 
(group B, 20 women) were referred for primary CABG. 
Patients with organic valvular disease were excluded. Ethical 
  committee approval was gained from the ethics committee 
of the University.
Demographic data for all patients, their classical 
cardiovascular risk factors and comorbidities are summarized 
in Table 1.
In group A, additional data regarding PCI and related 
vessels as well as number of stent implantation in total and 
per vessel were documented (Table 2).
Operative data including operative times, emergency 
status, number and kind of bypass grafts were recorded 
in all patients (Table 3). Data on postoperative course are 
displayed in Table 4. Aspects of intensive care stay, post-
operative blood loss, application of blood products and 
catecholamines were registered. Postoperative outcomes, 
complications, and mortality after a follow up of 5 years 
were obtained. Comparison of all data in both groups was 
established.
Statistical data analysis was carried out with R statistical 
software (http://www.r-project.org). Differences between 
the two groups were statistically assessed using Fisher’s 
exact test (for categorical variables) and the 2-sided 
Kolmogorov–Smirnov test (for continuous variables). The 
Kolmogorov–Smirnov test was applied because many vari-
ables did not fulfil, even approximately, the requirements of 
the t-test and the Mann–Whitney test. Multivariate analyses 
Table 1 Patient’s demographics, cardiovascular risk factors and comorbidities
Cardiovascular Risk  
Factors/Comorbidities 
Group A (n = 100)  
[Number of Patients,  
Percentage]
Group B (n = 100)  
[Number of Patients,  
Percentage]
P-value
Male/Female sex
Age [Years]
Arterial hypertension
80 (80%)/20 (20%)
63 ± 10,5
88 (88%)
80 (80%)/20 (20%)
65,9 ± 9,9
83 (83%)
ns
ns
ns
Diabetes mellitus 31 (31%) 26 (26%) ns
Hyperlipidemia 85 (85%) 84 (84%) ns
Peripheral arterial occlusive disease 23 (23 %) 14 (14%) ns
Body mass index [Mean in kg/m²] 26,38 ± 3,87 27,2 ± 3,9 ns
Dialysis 6 (6%) 3 (3%) ns
Transitory ischemic attack 4 (4%) 3 (3%) ns
Distribution of NYHA Class  0: 3%
I: 11%
II: 40%
III: 36%
IV: 10%
0: 0%
I: 3%
II: 51%
III: 41%
IV: 5%
0,025
Mean NYHA Class 2,39 + 0,92 2,48 + 0,64
Previous myocardial infarction 54 (54%) 34 (34%) 0,007
CAD  1: 11%
2: 23%
3: 67%
1: 27%
2: 40%
3: 33%
<0,0001
Number and percentage by vessel Left Main Stem: 3% 0 ns
Left ventricular ejection fraction 
[Mean and SD]
60,04 ± 14,5 60,47 ± 14,1 ns
Unstable angina pectoris  27 (27%) 5 (5%) <0,0001
LV aneurysm 5 (5%) 0 0,059Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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were performed using linear or logistic regression models, 
depending on the type of outcome. Statistical significance 
within multivariate models was assessed based on the Wald 
test. Overall survival was represented using Kaplan–Meier 
curves and the logrank test was used to compare the two 
groups. P-values ,0.1 were marked with “ns” in Tables 1–4. 
P-values ,0.05 were considered significant, whereas 
P-values between 0.05 and 0.1 were considered as trends.
Results
Demographic data, classic cardiovascular risk profile and 
comorbidities are listed in Table 1. Therapy with aspirin, 
GPIIb/IIIa inhibitors, ACE inhibitors, AT-I receptor 
blockers, calcium channel blockers, diuretics, statins, and 
nitrates showed an almost equal distribution among groups. 
Clopidogrel was administred in 35% of the patients with prior 
PCI and in 19% of patients without prior PCI (P = 0.016).
Table 2 includes all data regarding PCI in patients of 
group A. Almost half of this group underwent one PCI (48%). 
LAD was stented in 56 patients (56%), followed by RCA in 
47 patients (47%) and circumflex artery in 33%, either singly 
or in combination. Only 6 patients received stents in three 
coronary arteries. Mean duration between PCI and CABG 
was 321 days with a standard deviation of 502 days. This 
number may already show the big variance of evidence of 
clinical CAD symptoms.
Summarized intraoperative data for both groups are 
compared and listed in Table 3. All patients underwent 
CABG on cardiopulmonary bypass under cardioplegic 
hypothermic arrest. Time of extracorporeal circulation 
(130 vs 109 minutes; ns) revealed statistically nonsignificant 
differences between both groups.
The amount of blood saved by Cell Saver® was slightly 
lower in group B (616 ± 378 mL in group A vs 568 ± 333 mL 
in group B, respectively; ns). The mean number of established 
bypasses was 2.43 in group A vs 2.08 in group B (Fisher’s 
exact test: P = 0.017). Establishment of arterial bypass grafts 
showed the same trend: 1.26 vs 1.07 (Fisher’s exact test: 
P = 0.006). Left anterior descending artery was revascular-
ized by the left interior thoracic artery (LITA) in 80% of 
group A patients and 89% of group B patients (ns).
Most important for outcome evaluation are postopera-
tive parameters. Ventilation time and stay on intensive care 
unit did not demonstrate significant differences. Contrary 
to our expectation, the registered amount of bleeding 
48 hours postoperatively was slightly higher in group B 
(1345 ± 1113 mL vs 1055 ± 842 mL in group A; ns). 
A mean of 2.3 units of thrombocyte concentrate was 
used in 34 patients of group A and 1.6 units in 22 group 
B patients (ns). The amount of bleeding in both groups 
may be related to thrombocyte dosage, especially under 
the circumstance of being given preoperative antiplatelet 
medication. Neither the amount of erythrocyte concentrate 
nor the amount of fresh frozen plasmas was significantly 
Table 2 Group A PCI details prior to CABG
PCI 
(number of interventions as percentage) 
 
 
 
mean and SD 
1: 48% 
2: 28% 
3: 14% 
4: 7% 
5: 3% 
1.89 ± 1.08
Left main stem stenosis  3 (3%)
Target artery in n (%) 
LAD 
RCX 
RCA
 
56 (56%) 
33 (33%) 
47 (47%)
Multivessel PCI in n (%) 
RCX + RCA 
LAD + RCA 
LAD + RCX 
LAD + RCX + RCA
 
10 (10%) 
11 (11%) 
4 (4%) 
6 (6%)
Interval between PCI and CABG 
(mean time in days)
321.2 ± 501.8
Stents (mean number of implantations) 2.14 ± 1.32
Abbreviations: PCI, percutaneious coronary intervention; CABG, coronary artery 
bypass grafting; LAD, left anterior descending artery; RCA, right coronary artery; 
RCX, right circumflex artery; SD, standard deviation.
Table 3 Intraoperative data
Parameter Group A Group B P-value
Intraaortic balloon pump 3 (3%) 0 ns
Intubation before surgery 2 (2%) 0 ns
Emergency  3 (3%) 0 ns
Time of operation 
(minutes, mean ± SD)
269.6 ± 102.5 252.7 ± 78.7 ns
Cardiopulmonary bypass  
time (minutes, mean ± SD)
130.3 ± 66.8 109.3 ± 40.1 ns
Aortic cross clamp time 
(minutes, mean ± SD)
72.5 ± 30 65.6 ± 24.4 ns
Time of reperfusion 
(minutes, mean ± SD)
40.8 ± 26.5 36.3 ± 19.8 ns
Lowest temperature (°C) 30.2 ± 3.3 30.9 ± 2.3 ns
Amount of Cell Saver®  
blood (mL, mean ± SD)
616.1 ± 378 568.7 ± 333.1 ns
Number of established  
bypasses (mean ± SD)
2.43 ± 1.08 2.08 ± 1.08 0.017
Number of arterial  
bypass grafts (mean ± SD)
1.26 ± 0.82 1.07 ± 0.54 0.006
Number of venous  
bypass grafts (mean ± SD)
1.17 ± 1.03 1.02 ± 0.94 ns
LITA to LAD 80 (80%) 89 (89%) ns
Total RCA  21 (21%) 15 (15%) ns
Abbreviations: LITA, left internal thoracic artery; LAD, left anterior descending 
artery; RCA, right coronary artery; SD, standard deviation; ns, not significant.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
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different between groups. The dosage of adrenaline was 
not significantly different in the two groups (0.83 vs 
0.41 mg/h; ns). The difference in the mean was due to a 
small number of extreme values. However, the number 
of patients who received adrenaline was higher in group 
A than in group B (67 vs 47, respectively; P = 0.006). 
Mean noradrenaline dosage was approximately equal in 
the two groups (0.82 vs 0.87 mg/h; ns), and noradrenaline 
was administered in 46 group A vs 63 group B patients 
(P = 0.023). Six patients of group A were resuscitated 
postoperatively whereas no group B patient had to be 
resuscitated (P = 0.003). Myocardial markers CK and 
troponine I did show statistically significant differences 
between groups (P , 0.002; P , 0.001) with strongly 
higher levels in group A. Twelve group A patients needed 
an intraaortic balloon pump implantation postoperatively, 
whereas only one was implanted in patients of group B 
(P = 0.003).
30-day mortality was 9% in group A and 1% in group 
B (P = 0.018). This difference may be caused by several 
factors that will be discussed below. The five-year mortality 
rate was 14% in group A vs 9% in group B (logrank-test: ns, 
Figure 1). Five group A patients necessitated redo-CABG vs 
none of group B (ns).
In multivariate regression analyses with age, NYHA 
class, ejection fraction, and CAD as adjustment factors, 
prior PCI was not a significant predictor of postoperative 
bleeding, ventilation time, stay on intensive care unit, use 
of thrombocyte concentrate, use of erythrocyte concentrate, 
or fresh frozen plasma.
Table 4 Postoperative data
Parameter Group A Group B P-value
Postoperative bleeding 
(mL, first 48 hours, mean ± SD)
1055.10 ± 842.5 1345.54 ± 1113.8 ns
Ventilation time 
(hours, mean ± SD)
34.86 ± 58.03 31.64 ± 91.95 ns
Stay on intensive care unit (hours, mean ± SD) 70.46 ± 71.59 76.07 ± 111.75 ns
Use of thrombocyte concentrate  
(mean ± SD)
Total: 34 patients 
2.29 ± 1.45
Total: 22 patients 
1.64 ± 0.85
0.083 
ns
Use of erythrocyte concentrate  
(mean ± SD)
Total: 71 patients 
4.00 ± 4.57
Total: 58 patients 
3.62 ± 2.38
0.076 
ns
Use of fresh frozen plasma  
(mean ± SD)
Total: 39 patients 
6.92 ± 7.80
Total: 33 patients 
5.09 ± 3.14
ns 
ns
Adrenaline dosage  
(mg/h, mean ± SD)
Total: 67 patients 
0.83 ± 1.63
Total: 47 patients 
0.41 ± 0.26
0.006 
ns
Noradrenaline dosage  
(mg/h, mean ± SD)
Total: 46 patients 
0.82 ± 1.24
Total: 63 patients 
0.87 ± 2.11
0.023 
ns
Hydrocortisone use (number of patients) 28 36 ns
Creatinine, highest level (mg/dL, mean ± SD) 1.95 ± 1.6 1.61 ± 1.4 0.054
Creatine kinase, highest level 
(U/L, mean ± SD) 
CK-MB, highest level 
(U/L, mean ± SD) 
Troponin I, highest level 
(ng/mL, mean ± SD)
876.52 ±1815.83 
 
40.1 ± 53.14 
 
132.89 ± 206.10
414.29 ± 461.14 
 
24.8 ± 33.89 
 
106.54 ± 616.88
0.002 
 
0.059 
 
,0.001
Postoperative resuscitation 
(number of patients, percentage)
 
6 (6%)
 
0
 
0.029
Postoperative myocardial infarction 4 (4%) 0 ns
Neurological disorders 8 (8%) 4 (4%) ns
Postoperative atrial fibrillation  25 (25%) 35 (35%) ns
Postoperative acute renal failure 9 (9%) 3 (3%) ns
Wound infection 2 (2%) 4 (4%) ns
Intraaortic balloon pump 12 (12%) 1 (1%) 0.003
Rethoracotomy 8 (8%) 9 (9%) ns
In-hospital stay 
(days; mean ± SD)
11.1 ± 10 12.4 ± 5.7 ns
30-day mortality 9 (9%) 1 (1%) 0.018
Abbreviations: SD, standard deviation; ns, not significant.Vascular Health and Risk Management 2010:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
499
Outcomes of CABG patients with/without prior PCI
Discussion
Trials comparing PCI and CABG have demonstrated that 
long-term survival of PCI and CABG is similar, but rates 
of symptom recurrence and repeated revascularization are 
significantly higher in patients with initial PCI.10,12,16 With 
dramatic increase in PCI rates during the last decade,1,2 it is a 
consequence that the number of patients referred for CABG 
with a prior PCI has increased.21
Kalaycioglu et al22 compared 40 patients who had under-
gone CABG with a prior PCI with a case-matched control 
group of 40 patients who underwent CABG with no prior 
PCI. In contrast to our study, the authors found that patients 
with a prior PCI were younger, had a higher preoperative ejec-
tion fraction, less extensive coronary disease, and had fewer 
bypass grafts. After finishing this study, we agree with their 
results of diminished freedom from death, angina, and repeat 
revascularization procedure in the 36 months after surgery in 
patients with a prior PCI. In another study, Barakate et al23 
compared 361 patients who underwent CABG after initially 
successful PCI. Similar to the results from Hassan et al24 they 
demonstrated that patients with a prior PCI had a higher pre-
operative ejection fraction, less extensive coronary disease, 
and fewer bypass grafts, and were more likely to present with 
worsened symptoms. However, contrary to the findings from 
Hassan et al Barakate et al showed similar rates of in-hospital 
mortality between the 2 groups.
After analysis of our results, we found a stronger disease 
severity of CAD in group A (P , 0.0001). NYHA class 
distribution before surgery was significantly different among 
both groups (P = 0.025), 27 group A and 5 group B patients 
presented with unstable angina (P , 0.0001). Percentage of 
previous myocardial infarction differed significantly between 
both groups: 54% of group A and 34% of group B patients 
(P = 0.007). Clopidogrel was preoperatively administred in 
35% of the patients with prior PCI and in 19% of patients 
without prior PCI (P = 0.016).
Regarding intraoperative data, statistically significant 
results were demonstrated for group A and group B: the 
Kaplan–Meier curve
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mean number of established bypasses was significantly 
different among groups (2.43 vs 2.08, P = 0.017). The mean 
number of arterial bypass grafts used for revascularisation 
showed significant results as well (1.26 vs 1.07, P = 0.006). 
Left anterior descending artery was revascularized by LITA 
in 80% of group A patients and 89% of group B patients 
(ns). In search of causes for this diverse percentage of LITA 
graft use, we conjecture that severity of LAD calcification 
and placement of intracoronary stents, as well as emergency 
status of surgery, may be primary reasons for using this 
procedure.
During the postoperative course, statistically significant 
results could be registered for: frequency of adrenaline 
(P = 0.006) and noradrenaline (P = 0.023) administration, CK 
(P = 0.002) and troponine I (P , 0.001), and postoperative 
resuscitation (6 vs 0; P = 0.029). Even during perioperative 
duration, data leads to the supposition that the severity of 
disease seems to be higher and further advanced in group A. 
Contrary to our supposition, the amount of postoperative 
drainage loss was higher in group B (1345 ml) than in 
group A (1055 ml; ns). We expected, especially after clinical 
intraoperative impression, a higher bleeding rate in group 
A, mostly due to antiplatelet therapy. Blood product utiliza-
tion, especially of thrombocyte concentrates, was higher in 
group A (2.3 vs 1.6 units; ns) and may be one of the reasons 
for limited blood loss after surgery. Rethoracotomy rates 
were almost equal in both groups.
Twelve patients from group A received   postoperatively 
an  intraaortic  balloon  pump.  Only  one  patient  of 
group B necessitated an intraaortic balloon pump after 
  surgical procedure (P = 0.003).
30-day mortality was significantly lower in group B (9% 
vs 1%; P = 0.018). Five-year mortality was decreased in 
group B (14% in group A vs 9% in group B; ns). 83 patients 
of group A and 89 patients of group B showed NYHA class 
one or two after five years (ns). 16 group A patients under-
went re-PCI and stent implantation vs 13 of group B (ns). 
5 patients of group A and no patient of group B underwent 
redo-CABG (ns).
The reasons for a higher mortality in short and mid 
term after CABG in patients with prior PCI are not 
clearly understood. In our cohort, these patients had more 
comorbidity and increased coronary disease pathology, 
and presented for surgery with advanced symptoms and 
greater urgency. It might be that patients who had initial 
PCI had a more aggressive atherosclerotic onset promot-
ing a higher rate of restenosis and/or the development of 
new lesions at remote coronary sites.25 In addition, the 
application of successful PCI in these patients may have 
prevented the formation of protective collateral vessels, 
which resulted in the more acute presentation of patients 
who required repeated revascularization. Finally, prior 
PCI and, especially, stenting of a coronary lesion may 
have resulted in an anastomosis at a more distal site 
with a smaller luminal diameter and suboptimal runoff, 
thus compromising the degree to which the patient was 
completely revascularized.
Study limitations
This study has several limitations. It has been designed as a 
consecutive, observational, single center investigation. The 
number of enrolled patients limits the explanatory power of 
our study. Selection of patients of both groups may introduce 
an underlying bias.
We could not elaborate on the factors influencing 
the physicians’ and patients’ decisions to proceed with 
PCI or surgery first, noting that cardiothoracic surgeons 
do see patients usually after cardiologists have visited 
them. Even as we limited our analysis to short-term and 
  mid-term outcomes, it is plausible that different methods of 
follow-up for patients treated at or outside our institution 
could have led to some misclassification bias.The number 
of enrolled patients limits the explanatory power of our 
investigation.
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